Markers of epithelial-mesenchymal transformation in placentas with fetal growth retardation

Authors

DOI:

https://doi.org/10.18370/2309-4117.2025.79.51-56

Keywords:

fetal growth retardation, preeclampsia, epithelial-mesenchymal transformation, villous and extravillous cytotrophoblast, vimentin, cytokeratin 7

Abstract

Objective of the study: to study the phenomenon of epithelial-mesenchymal transformation in the placenta with fetal growth retardation (FGR).
Materials and methods. A study of placentas from 40 singleton births with FGR, divided into 4 groups, was conducted. Group I included pregnant women with FGR diagnosed before 32 weeks without concomitant gestational complications, group II included patients with FGR diagnosed up to 32 weeks and preeclampsia criteria, group III included pregnant women with FGR diagnosed after 32 weeks without concomitant gestational complications, group IV included pregnant women with FGR diagnosed after 32 weeks and concomitant preeclampsia. The control group consisted of 10 healthy parturient women.
The intensity of cytokeratin 7 and vimentin expression in extravillous and villous trophoblast cells and amnion was determined by an immunohistochemical direct immunoperoxidase method using microscopic morphometry in placental samples.
Results. In the extravillous trophoblast of the placenta against the background of FGR and preeclampsia and isolated early fetal growth retardation, increased expression of cytokeratin 7 was recorded: 0.471 standard units (SI) of light in group I, 0.437 SI of light in group II, 0.424 SI of light in group IV, 0.345 SI of light in the control group. At the same time, in the villous trophoblast, against the background of isolated FGR, a reduced expression of cytokeratin 7 was recorded: 0.345 SI of light in group I and 0.357 in group III versus 0.498 SI of light in the control group, and for concomitant preeclampsia even lower – 0.248 SI of light in group II and 0.239 SIof light in group IV.
Vimentin expression in extravillous trophoblast in FGR and preeclampsia, as well as in isolated early FGR, was lower than in the control group – 0.271 SI of light in group I, 0.237 SI of light in group II, 0.224 SI of light in group IV and 0.345 SI of light in healthy placentas. In villous trophoblast, vimentin expression was higher in placentas with FGR (0.375 SI of light in group I, 0.348 SI of light in group II, 0.387 SI of light in group III and 0.339 SI of light in group IV) than in healthy placentas (0.248 SI of light).
Conclusions. In the extravillous trophoblast of placentas with FGR and preeclampsia, as well as with isolated early FGR, insufficient acquisition of mesenchymal properties by cells (insufficient expression of vimentin) and preservation of epithelial properties (increased expression of cytokeratin 7) are observed. In the villous trophoblast of placentas with isolated FGR, excessive acquisition of mesenchymal cells and loss of epithelial properties were detected, and in the presence of concomitant preeclampsia, these changes are even more pronounced.

Author Biographies

T.O. Stepanenko, Dniprovsky District Consultive-Diagnostic Department, Kyiv

PhD, obstetrician-gynecologist

O.S. Zahorodnya, O.O. Bogomolets National Medical University, Kyiv

MD, professor, Department of Obstetrics and Gynecology No. 1

Y.B. Motsyuk, Ivano-Frankivsk National Medical University, Ivano-Frankivsk

PhD, associate professor, I.D. Lanovy Department of Obstetrics and Gynecology

M.I. Antoniuk, O.O. Bogomolets National Medical University, Kyiv

PhD, associate professor, Department of Obstetrics and Gynecology No. 1

References

  1. Leush S, Slobodianyk O, Osadchuk S, Ter-Tumasova A. The “brain-sparing” effect and thromboelastometric features of newborns with growth retardation. Reproductive endocrinology. 2024;73:45–50. DOI: 10.18370/2309-4117.2024.73.45-50.
  2. Arrindell J, Desnues B. Vimentin: from a cytoskeletal protein to a critical modulator of immune response and a target for infection. Front Immunol. 2023 Jul 5;14:1224352. DOI: 10.3389/fimmu.2023.1224352.
  3. Liu K, Wu S, Cui Y, et al. Trophoblast fusion in fetal growth restriction is inhibited by CTGF in a cell-cycle-dependent manner. J Mol Histol. 2024 Oct;55(5):895–908. DOI: 10.1007/s10735-024-10239-9.
  4. Leush, S, Govseiev, D, Protsyk, M. Discrepancies in the indicators of rotational thromboelastometry of umbilical cord blood in premature newborns after different types of tocolytic therapy. Reproductive Health of Woman. 2024;7:32–6. DOI: 10.30841/2708-8731.7.2024.315434
  5. Zats O, Sherstiuk S, Sydorenko R, et al. Expression of cytokeratin and vimentin in villi of the chorion with anteintranatal fetal death on the background of complicated pregnancy. The Journal of V.N. Karazin Kharkiv National University. Series «Medicine». 2023;46:43–56. DOI: 10.26565/2313-6693-2023-46-05
  6. Tymoshchuk KV, Zahorodnya OS. Markers of epithelial-mesenchymal transformation in the placenta and amniotic membranes by chorioamnionitis. Ukrainian Journal Health of Woman. 2025.1(176): 33–37. DOi: 10.15574/HW.2025.1(176).3337
  7. Bai R, Kusama K, Nakamura K, et al. Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium. FASEB J. 2018 Jun;32(6):3371–84. DOI: 10.1096/fj.201701131RR.
  8. Zhang S, Ding J, Wang J, et al. CXCL5 Downregulation in Villous Tissue Is Correlated With Recurrent Spontaneous Abortion. Front Immunol. 2021 Sep 17;12:717483. DOI: 10.3389/fimmu.2021.717483.
  9. Afshar Y, Kashani Ligumsky L, Bartels HC, Krakow D. Biology and Pathophysiology of Placenta Accreta Spectrum Disorder. Obstet Gynecol. 2025 Jun 1;145(6):611–20. DOI: 10.1097/AOG.0000000000005903.
  10. Tiulienieva I, Davydenko I, Yasnikovska O, Tiulienieva V. Immunohistochemical evaluation of vimentin in endothelium of vessels uero-placental bed during iron deficiency anemia in pregnancy. Сlinical and experimental pathology 2022;21;2(80):22–7. DOI:10.24061/1727-4338. XXI.2.80.2022.04
  11. Klinichna nastanova, zasnovana na dokazakh «Zatrymka rostu ploda» [Internet]. State Expert Center of the Ministry of Health of Ukraine, 2023. Available from: https://www.dec.gov.ua/wp-content/uploads/2023/10/2023_nastanova-zrp.pdf
  12. Klinichna nastanova, zasnovana na dokazakh «Hipertenzyvni rozlady pry vahitnosti» [Internet]. State Expert Center of the Ministry of Health of Ukraine, 2021. Available from: https://www.dec.gov.ua/wp-content/uploads/2022/01/2022_151_kn_giprozlvagitn.pdf
  13. Oghbaei F, Zarezadeh R, Jafari-Gharabaghlou D, et al. Epithelial-mesenchymal transition process during embryo implantation. Cell Tissue Res. 2022 Apr;388(1):1–17. DOI: 10.1007/s00441-021-03574-w.
  14. Bai R, Kusama K, Nakamura K, et al. Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium. FASEB J. 2018 Jun;32(6):3371–84. DOI: 10.1096/fj.201701131RR. J. 2018 Jun;32(6):3371–84. DOI: 10.1096/fj.201701131RR.
  15. Lowery J, Kuczmarski ER, Herrmann H, Goldman RD. Intermediate filaments play a pivotal role in regulating cell architecture and func tion. J Biol Chem. 2015;290(28):17145–53. DOI: 10.1074/jbc. R115.640359.
  16. Tkalich V, Bila V, Zahorodnia O. Markery epitelialno-mezenkhimalnoi transformatsii u platsentakh vid duzhe rannikh peredchasnykh polohiv [Markers of epithelial-mesenchymal transformation in placentas from very early preterm births]. Reproductive health of woman. 2024;6(77):51–6. DOI: https://doi.org/10.30841/2708-8731.6.2024.313543
  17. Menon R, Boldogh I, Hawkins H, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol. 2014. 184(6):1740–51. DOI: 10.1016/j.ajpath.2014.02.011.
  18. DomagaЕ‚a Z, MroЕјek A, Piotrowska A, et al. Expression of selected cytokeratins in human placenta - a preliminary observational study. Medical Journal of Cell Biology. Sciendo, 2022;10 (4): 155–62. DOI: 10.2478/acb-2022-0023
  19. Khaing A, Swe AT, Aung CL, et al. Expression of Endothelin-1 and Endothelial Nitric Oxide Synthase in Normal and Preeclamptic Placentae. Rev Bras Ginecol Obstet. 2022 Feb;44(2):125–32. DOI: 10.1055/s-0042-1742317.
  20. Chen L, Shi Q, Fan B, Cai Y. Role of lncRNA BCYRN1 in trophoblast cell physiology and pathogenesis of preeclampsia. Exp Ther Med. 2021 Oct;22(4):1137. DOI: 10.3892/etm.2021.10571.
  21. Umapathy A, Clark A, Sehgal A, et al. Molecular regulators of defective placental and cardiovascular development in fetal growth restriction. Clin Sci (Lond). 2024 Jul 3;138(13):761–75. DOI: 10.1042/CS20220428.
  22. Pastuschek J, Nonn O, GutiГ©rrez-Samudio RN, et al. Molecular characteristics of established trophoblast-derived cell lines. Placenta. 2021 May;108:122-133. DOI: 10.1016/j.placenta.2021.02.022.
  23. İrtegun S, Ali Tekin M, Alpayc R/ Increased Expression of E-cadherin, Endothelin-1, and CD68 in Preeclamptic Placentas. J Clin PraСЃt Res 2016; 38(4): 149–52/DOI: 10.5152/etd.2016.0090
  24. Wong GP, Hartmann S, Simmons DG, et al. Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction. Stem Cell Rev Rep. 2024 Oct;20(7):1954–70. DOI: 10.1007/s12015-024-10764-w.
  25. Yanchevsky OV. Features and staging of epithelial-mesenchymal transformation of small cell lung cancer. Bull Probl Biol Med. 2023;168(1):352–9. DOI: 10.29254/2077-4214-2023-1-168-352-359.

Published

2025-09-18

How to Cite

Stepanenko, T., Zahorodnya, O., Motsyuk, Y., & Antoniuk, M. (2025). Markers of epithelial-mesenchymal transformation in placentas with fetal growth retardation. REPRODUCTIVE ENDOCRINOLOGY, (79), 51–56. https://doi.org/10.18370/2309-4117.2025.79.51-56

Issue

Section

Pregnancy and childbirth